Sign inJoin waitlistJoin the waitlist

OT

Olga Tsvetkova

Credentials:

History

Residency
2023–2026
Medical School
2019–2023

Research

Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial
Nature Communications · 2026 · 1 citations
Evaluating datopotamab deruxtecan (Dato-DXd) as a novel treatment option for EGFR-mutated non-small cell lung cancer
Review · Future Oncology · 2026 · First of 10 authors

Aaron Lisberg
1 paper
AP
Alykhan Premji
1 paper · 1 as a resident
AS
Ann Siney-Yeh
1 paper
David Dawson
1 paper
Deborah Wong
1 paper
Joe Hines
1 paper
Jonathan King
1 paper
Lee Rosen
1 paper
Maria Velez
1 paper
Mark Girgis
1 paper
MH
McKensie Hammons
1 paper · 1 as a resident
MS
Michael Srienc
1 paper · 1 as a resident